Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1977;55:449-455

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franciosa, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franciosa, J. A.

Circulation, Vol 55, 449-455, Copyright © 1977 by American Heart Association


ARTICLES

Evaluation of the CO2 rebreathing cardiac output method in seriously ill patients

JA Franciosa

The CO2 rebreathing cardiac output method is a totally noninvasive Fick procedure needing validation in various disease states to become clinically applicable. Simultaneous measurements of cardiac output by CO2 rebreathing and dye-dilution or direct Fick techniques were performed in 53 patients. In nine patients with pulmonary disease rebreathing cardiac output averaged 4.85 L/min compared to 5.18 L/min by dye-dilution or Fick (r = 0.16). In 14 instances of acute myocardial infarction cardiac output was 5.53 L/min by rebreathing and 5.87 L/min by dye-dilution (r = 0.95), while in nine shock cases it averaged 3.98 L/min by dye-dilution or Fick and 3.75 L/min by CO2 rebreathing (r = 0.94). In five heart failure cases with mitral insufficiency, which may distort dye durves, correlation between standard and rebreathing methods was r = 0.09, but in 16 cases without mitral regurgitation, r = 0.89. Acute interventions in ten patients increased dye-dilution cardiac output by 0.92 L/min and rebreathing outputs by 0.60 L/min (r = 0.87). The data suggest that the CO2 rebreathing cardiac output method may be useful in the CCU-MICU setting.


This article has been cited by other articles:


Home page
ChestHome page
S.-D. Lee, D.-S. Kim, T.-S. Shim, C.-M. Lim, Y. Koh, W.-S. Kim, and W.-D. Kim
Nitric Oxide and Molsidomine in the Management of Pulmonary Hypertension in Takayasu's Arteritis
Chest, January 1, 2001; 119(1): 302 - 307.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
T. W HIGENBOTTAM, M. ASIF, K. MCCORMACK, T. E SIDDONS, E. A G DEMONCHEAUX, K. ASHUTOSH, and K. PHADKE
Use of nitric oxide inhalation in COPD
Thorax, November 1, 2000; 55(11): 978 - 978.
[Full Text]


Home page
ANGIOLOGYHome page
G. Simon, J. A. Franciosa, and J. N. Cohn
Decreased Venous Distensibility in Essential Hypertension: Lack of Systemic Hemodynamic Correlates
Angiology, March 1, 1979; 30(3): 147 - 159.
[Abstract] [PDF]